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Background and Aims: Surface expression of  platelet markers enhanced during 
ischemic events and appear to play an important role in myocardial repair. Stromal 
cell-derived factor-1 (SDF-1) is one of these factors which its effects Mediated through 
CXCR4 and CXCR7 receptors. In our study we are going to determine the surface 
expressions of platelet markers  and the changes of left ventricle ejection fraction in 
patients with coronary artery disease.
Materials and Methods: This descriptive cross-sectional study measured the superfi-
cial expression of platelet indices (SDF-1R, CXCR4, and CXCR7) and its association 
with the changes of the left ventricle ejection fraction in patients with coronary artery 
disease who have referred to Taleghani Hospital, Tehran in 2017-2018. 
Results: Among all patients referred to Taleghani Hospital with symptoms of coronary 
artery disease, 57 patient had inclusion criteria. this study demonstrated that mean 
SDF1 and CXCR4 level were respectively 1.1 and 2.3 which there  were significant 
difference between those with severe EF reduction comparing to the rest of the groups 
(respectively P<0.002 & P<0.004 ). The mean CXCR7 value of all patients was 3.5 
(SD= 0.27) and showed a significant difference in patients with severe (6) and low (4.7) 
ejection fraction reductions compared to those with moderate (2.5) and normal (2.8) 
ejection fraction reductions (P<0.009). 
Conclusion: Results from this study suggest that the level of surface expression of 
platelet markers (SDF-1, CXCR4, CXCR7) in patients with coronary artery disease who 
had severe LV dysfunction rise sharply compared to those with normal ejection fraction, 
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This descriptive cross-sectional study measured the su-
perficial expression of platelet indices (SDF–1R, CXCR4, 
CXCR7) and the left ventricle EF changes in patients with 
coronary heart disease who were referred to Taleghani Hos-
pital  during the years 2017-2018. Patients aged 18-60 years 
of age, who have referred to the hospital with symptoms of 
coronary heart disease and were admitted for angiography 
were included. The exclusion criteria were any history of 
revascularization, cancer and chemotherapy, platelet dis-
orders and acute and chronic bleeding, and the consump-
tion of medications with hematologic complication. Those 
who with history of receiving blood and platelet products 
during the last three months also were excluded as well. 
The consent forms were taken from the patients in case of 
a willingness to participate in this study. We get our ethi-
cal approval from shahid Beheshti University of medical 
sciences ethical center with ethical code 1398,12 .To mea-
sure the precise function of left ventricle and EF changes, 
Echocardiography were used after the angiography. In this 
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cant. Also, a post hoc analysis (in our study, Scheffe post 
hoc test) was used in order to investigate the association 
between subgroups. In this study, participants’ information 
remained confidential, and participation was not compul-
sory. Written consent was taken from all participants, and 
the ethical regulations were based on the provision of the 
Helsinki convention and acquiesced from the ethical com-
mittee.
RESULTS
A total of 57 patients who have referred to Taleghani Hos-
pital with coronary artery disease symptoms were included 
in this study. All participants underwent echocardiography; 
33 patients were in normal group and 10 patients have mild 
LV systolic dysfunction , 7 patients were diagnosed with 
moderate LV systolic dysfunction, and 7 patients were cat-
egorized as having severe LV function reduction. 
Table 1 presents the mean values of SDF-1R, CXCR4, and 
CXCR7 in the groups. The mean SDF-1R value in all pa-
tients was 1.11, and there was only a significant difference 
in patients with severe EF reduction comparing to the rest 
of the people (p < 0.002).
The mean level of CXCR4 in all patients was 2.3, which 
showed only a significant difference between patients with 
severe reduction in ejection fraction (3.2) compared to oth-
er groups (moderate LV systolic dysfunction (2.1) and Mild 
Dysfunction (2.3) and patients with  normal LV Function 
(2/2)) (P = 0.004).
The mean measure of CXCR7 among all patients was 3.5, 
and it had significant differences in groups of severe (6) 
and low (4.7) EF reductions compared to patients with 
moderate LV systolic dysfunction (2.5) and normal LV fuc-
tion (2.8) EF reductions (P<0.009), as illustrated in table 1.
regard, the EF > 55% was an indicator of normal function, 
EF 40-50% was a sign of mild LV  dysfunction, EF 30-40% 
showed a modeate Lv dysfunction, and EF <30% suggested 
a severe reduction of left ventricle function [11].
The blood platelet indices count (SDF – 1R, CXCR4, 
CXCR7) was estimated by a 10 cc fasting blood sample 
that was taken from all patients, and the level of SDF – 1R, 
CXCR4, and CXCR7 factors was measured by flow cytom-
etry analysis. 
The collected data were analyzed by SPSS version 25, and 
the normality of the data was assessed by the Kolmogor-
ov-Smirnov test. Normal distribution of the data for the 
ECG-based comparison of platelet factor, the AVONA test 
was used, and values below 0.05 were considered signifi-
cant. Also, a post hoc analysis (in our study, Scheffe post 
hoc test) was used in order to investigate the association 
between subgroups. In this study, participants’ information 
remained confidential, and participation was not compul-
sory. Written consent was taken from all participants, and 
the ethical regulations were based on the provision of the 
Helsinki convention and acquiesced from the ethical com-
mittee.
MATERIALS and METHODS
This descriptive cross-sectional study measured the super-
ficial expression of platelet indices (SDF – 1R, CXCR4, 
CXCR7) and the left ventricle EF changes in patients with 
coronary heart disease who were referred to Taleghani Hos-
pital  during the years 2017-2018.. Patients aged 18-60 
years of age, who have referred to the hospital with symp-
toms of coronary heart disease and were admitted for angi-
ography were included. The exclusion criteria were any his-
tory of revascularization, cancer and chemotherapy, platelet 
disorders and acute and chronic bleeding, and the consump-
tion of medications with hematologic complication. Those 
who with history of receiving blood and platelet products 
during the last three months also were excluded as well. 
The consent forms were taken from the patients in case of 
a willingness to participate in this study. We get our ethi-
cal approval from shahid Beheshti University of medical 
sciences ethical center with ethical code 1398,12 .To mea-
sure the precise function of left ventricle and EF changes, 
Echocardiography were used after the angiography. In this 
regard, the EF > 55% was an indicator of normal function, 
EF 40-50% was a sign of mild LV  dysfunction, EF 30-40% 
showed a modeate Lv dysfunction, and EF <30% suggested 
a severe reduction of left ventricle function [11].
The blood platelet indices count (SDF – 1R, CXCR4, 
CXCR7) was estimated by a 10 cc fasting blood sample 
that was taken from all patients, and the level of SDF – 1R, 
CXCR4, and CXCR7 factors was measured by flow cytom-
etry analysis. 
The collected data were analyzed by SPSS version 25, and 
the normality of the data was assessed by the Kolmogor-
ov-Smirnov test. Normal distribution of the data for the 
ECG-based comparison of platelet factor, the AVONA test 
was used, and values below 0.05 were considered signifi-
Platelet Markers and LVEF in CAD
Table 1. Patients’ distribution based on the platelet indices count and 
EF reduction (LV= Left ventricle, SD= Standard deviation)
Platelet 
Marker LV systolic function Mean SD
SDF1
Normal 1.07 0.24
Mild Dysfunction 1.00 0.22
Moderate Dysfunction 1.07 0.08




Mild Dysfunction 2.29 0.7
Moderate Dysfunction 2.14 0.55




Mild Dysfunction 4.68 0.44
Moderate Dysfunction 2.49 0.05
Sever Dysfunction 6.04 0.38
Total 3.52 0.27
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DISCUSSION
This study suggest that the surface expressions of platelet 
markers (SDF-1, CXCR4, CXCR7) was increased in pa-
tients with coronary artery disease and severe left ventri-
cle dysfunction compared to patients with normal EF and, 
therefore, can be used as an indicator to evaluate the level 
of damage caused by the coronary artery disease.
The expression of stromal cell-derived factor-1 (SDF-1) on 
the outer surface of platelets in ischemia plays an essential 
role in the myocardial damage recovery, leading to the mi-
gration of progenitor cells from the bone marrow to the site 
of injury. The CXCR4 and CXCR7 factors mediate the ef-
fect of SDF-1 and increase after injury or severe ischemia. 
Our results were in agreement with the 2017 study of Kiani 
and colleagues [12], who have suggested that any damages 
to the heart tissue lead to the inflammatory chemical secre-
tion of SDF – 1, and subsequently, the increase of CXCR7 
and CXCR4 expression in blood cells. In another study 
by Mayorga and colleagues in 2018 [13], the mesenchy-
mal stem cells (MSC) isolated from the green fluorescent 
proteins (GFP) were induced to increase the expression of 
SDF-1 expression. In this study, the administration of MSC 
significantly improved the EF in control and diabetic rats 
21 days after acute myocardial infarction, an outcome that 
was in line with our findings.
Based on a 2014 study by Rath and colleagues, the clini-
cal potential of the CXCR7 platelet expression level is an 
influential factor in mediating the beneficial role of SDF-1 
on improving performance in patients with acute coronary 
disease. Surprisingly, in our study the rate of CXCR7 in the 
group with mild LV systolic dysfunction was more than that 
of patients with moderate left ventricle dysfunction, which 
can be partly explained by the small study population in 
our study; therefore, inadequate power for statistical anal-
yses. However, Schiller and colleagues [14] have neither 
reported a significant correlation with platelet expression 
level of CXCR4 and CXCR7 after assessing serum SDF-1 
levels among 160 patients with coronary heart disease, as 
a result, further investigation of this factor will be recom-
mended in future studies. Another limitation of our study is 
to conduct this study with small sample size from a single 
health center; therefore, broader multi-central studies with 
larger sample sizes might be required for the adaptation of 
the results to the general population.
CONCLUSION
In conclusion, based on the results of this study, it can be 
said that the level of surface expression of platelet markers 
(SDF-1, CXCR4, CXCR7) in patients with coronary artery 
disease who had severe left ventricle ejection fraction re-
duction rise sharply compared to those with normal ejection 
fraction, therefore, these platelet markers can be used as 
an index for the assessment of myocardial damage and left 
ventricular severe EF reduction.
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